Trametinib, sold under the brand name Mekinist among others, is an anticancer medication used for the treatment of melanoma and glioma. It is a MEK inhibitor...
15 KB (976 words) - 17:10, 20 October 2024
rash, joint pain, fever and tiredness. When taken in combination with trametinib, the most common side effects include fever, tiredness, nausea, chills...
16 KB (1,122 words) - 00:37, 17 February 2025
BRAF inhibitors, such as vemurafenib and dabrafenib and a MEK inhibitor trametinib are the most effective, approved treatments for BRAF positive melanoma...
157 KB (16,418 words) - 12:43, 24 April 2025
of NSCLC) can be treated by dabrafenib combined with the MEK inhibitor trametinib; those with activated ROS1 (around 1% of NSCLC) can be inhibited by crizotinib...
89 KB (9,743 words) - 00:04, 28 March 2025
evaluated as a combination treatment against solid tumors together with trametinib in a clinical trial sponsored by the National Cancer Institute. In this...
13 KB (1,295 words) - 07:06, 24 November 2024
BRAF inhibitors, such as vemurafenib and dabrafenib; or a MEK inhibitor trametinib may be used. When arising in the nailbed of a digit, the evidence suggests...
24 KB (2,392 words) - 20:50, 6 February 2025
BRAF inhibitors, such as vemurafenib and dabrafenib; and a MEK inhibitor trametinib. Important prognosis factors for nodular melanoma include: Thickness Ulceration...
4 KB (386 words) - 15:36, 21 May 2024
are tyrosine kinase inhibitors that may also cause MG), dabrafenib, and trametinib; 3) antipsychotic drugs, i.e., chlorpromazine, pimozide, thioridazine...
81 KB (8,717 words) - 11:57, 10 April 2025
metastatic melanoma that harbors BRAF V600E mutation MEK inhibitors (trametinib, MEK162) are used in experiments, often in combination with BRAF inhibitors...
21 KB (2,364 words) - 08:31, 24 March 2025
Rosuvastatin Crestor 1.37 in hemodialysis patients Lisinopril Prinivil and others 1.38 Ivacaftor Kalydeco 2.2–2.9 Trametinib Mekinist 6.0 at 2 mg once daily...
4 KB (432 words) - 05:16, 4 July 2024
thyroid cancer harboring such mutations. The combination of dabrafenib and trametinib has shown significant increases in overall survival and has been approved...
20 KB (2,157 words) - 16:35, 7 January 2025
Fecher, Leslie A.; et al. (2012). "Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial"....
3 KB (296 words) - 17:06, 14 September 2023
chemotherapeutic treatment, dacarbazine. Dabrafenib in combination with trametinib was approved by FDA in June 2022 for treatment of all metastatic BRAF...
50 KB (5,393 words) - 08:57, 15 March 2025
BRAF inhibitors, such as vemurafenib and dabrafenib; and a MEK inhibitor trametinib. In February 2024, the Food and Drug Administration approved the first...
58 KB (6,500 words) - 10:05, 13 April 2025
at Moffitt Cancer Center discovered two monotherapy drugs – Mekinist (trametinib) and Tafinlar (dabrafenib) – can be safely combined to overcome or delay...
30 KB (2,947 words) - 20:27, 9 April 2025
cobimetinib, CI-1040, PD0325901, binimetinib (MEK162), selumetinib, and trametinib (GSK1120212) It has been found that acupoint-moxibustion has a role in...
24 KB (3,068 words) - 07:21, 7 June 2024
Ceritinib L01ED03 Alectinib L01ED04 Brigatinib L01ED05 Lorlatinib L01EE01 Trametinib L01EE02 Cobimetinib L01EE03 Binimetinib L01EE04 Selumetinib L01EE05 Mirdametinib...
13 KB (932 words) - 04:36, 23 December 2024
for medical use in the United States in September 2020. Dabrafenib and trametinib have been approved as tissue-agnostic drugs for solid tumors that are...
7 KB (597 words) - 15:52, 6 August 2024
Ruxolitinib MAP2K (MEK) Binimetinib Cobimetinib Mirdametinib Selumetinib Trametinib EML4-ALK Crizotinib Entrectinib Lorlatinib Bruton's (BTK) Acalabrutinib...
12 KB (821 words) - 11:51, 17 February 2025
Lilly/Boehringer) tralokinumab (INN) tralonide (INN) tramadol (INN) tramazoline (INN) trametinib (USAN, INN) tramiprosate (USAN) Trancopal Trandate trandolapril (INN)...
12 KB (565 words) - 02:11, 29 March 2025
include uveal melanoma (failed), and differentiated thyroid carcinoma. Trametinib (GSK1120212), FDA-approved to treat BRAF-mutated melanoma. Also studied...
6 KB (718 words) - 14:19, 13 January 2025
including Octreotide, Sirolimus, Anti-plasmin and, at least in one case, Trametinib. Dog breeds commonly affected by lymphangiectasia and/or protein-losing...
10 KB (1,002 words) - 06:53, 6 January 2024
inhibitors, such as vemurafenib and dabrafenib; and an MEK inhibitor trametinib. Melanoma List of cutaneous conditions James, William D.; Berger, Timothy...
5 KB (346 words) - 10:52, 28 March 2024
Novartis Pharmaceuticals melanoma with BRAF V600E or V600K mutations Trametinib Novartis Pharmaceuticals melanoma with BRAF V600E or V600K mutations Dabrafenib...
45 KB (240 words) - 04:36, 21 January 2025
including Octreotide, Sirolimus, Anti-plasmin and, at least in one case, Trametinib. The disease was first reported in 1961 by T.A. Waldmann. He described...
8 KB (821 words) - 01:15, 1 February 2025
can be tried. Or a BRAF inhibitor can be restarted plus MEK inhibitors trametinib or cobimetinib. Interferon-alpha is an immune system hormone that is very...
53 KB (6,568 words) - 12:17, 11 April 2025
trial results compared vemurafenib with the combination of dabrafenib and trametinib for metastatic melanoma. Vemurafenib was approved in the United States...
21 KB (1,816 words) - 17:00, 20 April 2025
human patients with a kidney disease. By combining doses of lithium, trametinib and rapamycin into a single treatment, researchers extend the lifespan...
206 KB (19,135 words) - 14:28, 19 April 2025
ALK inhibitors with MEK inhibitors: brigatinib+binimetinib, ceritinib+trametinib, and alectinib+cobimetinib. Results for the last two are expected around...
17 KB (1,951 words) - 10:39, 25 January 2024
retinoids to relieve symptoms but it may increase pain. Selumetinib and trametinib have been shown to reduce and control tumor growth in people with neurofibromatosis...
23 KB (2,533 words) - 11:38, 17 March 2025